| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.8M | — | +99.2% |
| SG&A Expense | $1.9M | — | +12.0% |
| Operating Income | -$5.7M | — | -58.4% |
| Pre-tax Income | -$9.9M | — | -961.0% |
| Income Tax | -$35K | — | +73.7% |
| Net Income | -$9.9M | — | -1130.9% |
| EPS (Basic) | -$4.41 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.6M | -3.9% | +68.9% |
| Accounts Receivable | $2K | -85.3% | -98.5% |
| Current Assets | $14.0M | -7.2% | +65.5% |
| Total Assets | $27.3M | -4.4% | +19.3% |
| Current Liabilities | $5.1M | +21.4% | +100.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | +14.4% |
| Financing Cash Flow | $3.3M | — | +1531.2% |
| — |
| EPS (Diluted) | -$4.41 | — | — |
| $14.8M |
| +54.7% |
| +153.7% |
| Stockholders' Equity | $12.5M | -34.2% | -26.7% |